Mara has a particular interest in melanocytic lesions and inflammatory skin conditions, excluding lymphoma. Her expertise is highlighted by several notable publications, including "Epitheliod Haemangioendothelioma Presenting in the Skin: A Clinicopathologic Study of Eight Cases" published in the American Journal of Dermatopathology, and "Deep Penetrating Naevus: Clinicopathological Study of 31 Cases" in Histopathology. She has also contributed to research on metastatic spread in ductal breast cancer and cutaneous infections. Dr. Quante's extensive research and clinical practice have significantly advanced the understanding and treatment of complex dermatopathological conditions. Her contributions to the field are widely recognized, making her a leading expert in diagnosing and studying skin-related diseases

Dr. Andrew R Bamber is a highly accomplished consultant in paediatric and perinatal pathology. He holds a Doctor of Medicine (Research) from University College London, a postgraduate diploma in forensic medicine and science (with distinction) from the University of Edinburgh, and a Bachelor of Medicine, Bachelor of Surgery from the University of Cambridge. Dr. Bamber has published extensively on topics such as sudden infant death and Kawasaki disease. He is currently a consultant paediatric and perinatal pathologist at North Bristol NHS Trust and an honorary consultant paediatric pathologist at Cardiff and Vale University Health Board. He has received prestigious awards, including the Pediatric Pathology Society Normal Brown Award and the Lucas Medal in Forensic Medicine from the University of Edinburgh. Dr. Bamber is actively involved in esteemed societies and associations, including the British Association in Forensic Medicine and the Children's Cancer and Leukaemia Group.

‍

He was appointed as a Consultant Cardiothoracic and Transplant Pathologist at The Royal Brompton and Harefield Clinical Group as part of the Guy’s and St Thomas’ NHS Foundation Trust in February 2015. Besides his specialist interest in lung and cardiac pathology, he is also an Associate Clinical Chief Information Officer and Medical Information Officer at Guy’s and St Thomas’ NHS Foundation Trust. At The Royal Brompton and Harefield Clinical Group he is clinical lead for computational pathology.

He is an Honorary Senior Clinical Lecturer at the Faculty of Medicine, National Heart and Lung Institute, Imperial College London and visiting Professor at the University of Antwerp. His main research interests are Artificial Intelligence, computational pathology, specifically in the areas of lung pathology and specifically thoracic oncology, cardiovascular disease, cardiac and pulmonary transplantation.

Dr Christophe Rosty is a highly accomplished anatomical pathologist with a sub-speciality in GI pathology. He has a strong interest in colorectal cancer, colorectal polyps, familial predisposition to colorectal cancer, polyposis syndromes, and GI molecular pathology. With a career spanning several decades, Dr Rosty has made significant contributions to his field through his numerous publications. He has authored or co-authored 151 peer-reviewed articles, which have amassed over 12,600 citations, giving him an H-index of 57. Dr Rosty is also a co-author of the WHO classification Tumours books on Digestive System Tumours and Genetic Tumour Syndromes, which are widely regarded as authoritative references on these topics.

‍

She holds an MD degree from Tehran University of Medical Sciences, Iran, and has undergone extensive postgraduate training and specialization in the field of Anatomical Pathology. Dr. Rouzbahman is a Fellow of Anatomical Pathology at the Royal College of Physicians and Surgeons of Canada. She is also licensed by the Medical Council of Canada and the College of Physicians and Surgeons of Ontario.

Currently, Dr. Rouzbahman holds key positions at the University Health Network and Toronto General Hospital in Toronto, Ontario, Canada. She serves as a Staff Pathologist in the Division of Anatomical Pathology at the University Health Network, where she has been actively involved in the clinical practice of gynecological pathology. She is also an Associate Professor in the Division of Anatomical Pathology at the Department of Laboratory Medicine and Pathobiology, University of Toronto. Dr. Rouzbahman has made significant contributions to the field of gynecologic oncology through her research, teaching, and clinical practice.

Her primary focus is on studying rare and unusual malignant neoplasms of the female genital tract, with the aim of developing diagnostic criteria and identifying biomarkers to aid in the diagnosis and management of these rare tumors. She is particularly interested in biomarkers in gynecologic pathology, which include specific proteins, genetic markers, or molecular signatures that provide valuable information for personalized treatment planning and monitoring the response to therapy.

Dr. Rouzbahman has been actively involved in various research projects related to gynecologic pathology, including Her2-Neu testing in uterine serous carcinoma, and the exploration and validation of Her2-Neu in ovarian mucinous adenocarcinoma. She has also focused on malignant mesenchymal neoplasms of the uterus, such as leiomyosarcoma, endometrial stromal sarcoma, adenosarcoma, and other rare entities. Her work has led to several publications, citations, lectures, and workshops, contributing to the advancement of gynecologic pathology.

In summary, Dr. Marjan Rouzbahman is a dedicated pathologist and researcher with a strong commitment to advancing the understanding and diagnosis of gynecologic malignancies. Her work in biomarker analysis and the classification of rare gynecological tumors has made her a valuable contributor to the field, both in Canada and internationally.

With a focus on Hematopathology, he has a keen interest in Hodgkin and non-Hodgkin Lymphomas, Myelodysplastic Syndrome (MDS), and Histiocytic neoplasms. Dr. Sakhdari's expertise and dedication are evident through his contributions to the field, with a notable portfolio of publications reflecting his research interests.

Affiliated with the prestigious University Health Network and the University of Toronto, Dr. Sakhdari plays a crucial role in advancing education, research, and patient care within the academic community. His commitment to excellence in pathology, combined with his academic affiliations, positions Dr. Ali Sakhdari as a respected figure in the field, shaping the future of pathology in Canada and beyond.

Dr. Saxena received her medical qualifications from Bombay University, India, including an MBBS and MD in Pathology, before achieving further accreditation as a Fellow of the Royal College of Pathologists (FRCPath) in the UK.

She has established herself as a notable authority in liver pathology and has contributed significantly to the field through her academic and clinical roles. Dr. Saxena serves as the Director of the Liver Pathology Service and the Medical Director of the Histology Laboratory at Emory University School of Medicine. Her role also includes directing the Gastrointestinal and Liver Pathology Fellowship.

Throughout her illustrious career, she has been deeply involved in research, particularly in liver pathophysiology, liver diseases, and hepatic neoplasms. Dr. Saxena has a remarkable record of publications in esteemed journals such as the American Journal of Surgical Pathology, Journal of Clinical Oncology, Seminars in Diagnostic Pathology, and Virchows Archiv, among others. Her research has delved into various aspects of liver diseases, diagnostic approaches, and therapeutic interventions, encompassing a broad spectrum of topics from primary liver tumors to drug-induced liver injury and hepatic fibrosis.

Dr. Saxena has played a pivotal role in shaping international standards in pathology, serving as an editorial board member for prestigious journals like Pathology and Modern Pathology. She has also been an active participant in various committees and professional societies, including the American Association for the Study of Liver Diseases and the United States and Canadian Association of Pathologists, where she contributes as a reviewer and mentor.

Her extensive academic journey spans across multiple continents, with academic appointments at distinguished institutions including King's College Hospital in London, Mount Sinai School of Medicine in New York, and Indiana University School of Medicine, among others. Dr. Saxena has been an invited lecturer at numerous conferences and has directed several teaching courses on liver pathology, demonstrating her commitment to education and mentorship in the field.

Dr. Romil Saxena's enduring dedication to liver pathology, extensive research contributions, commitment to education, and leadership in the field have established her as a revered figure in the realm of pathology and liver sciences.

Specializing in Histopathology, her sub-specialties include Gastrointestinal Pathology, Head and Neck Pathology, Hepatopathology, and non-gynae cytology.

Dr. Sleigh's primary interest lies in colorectal cancer, and she has made significant contributions to the field through her research and publications. Notable works include "Multicentre Investigation of Prognostic Factors for Anal Cancer after Chemoradiotherapy" published in Clinical Oncology.

Affiliated with University Hospitals Sussex, Dr. Sleigh also serves as an educational supervisor within the KSS deanery, demonstrating her commitment to training the next generation of pathologists. With her expertise and dedication to advancing knowledge in histopathology, Dr. Kerry Sleigh is a respected figure in the medical community.

Anuj is board-certified in AP/CP and is the Chairman of the Quest Diagnostics/AmeriPath GI and Liver Resource Committee. Dr.Sonawala's professional interests are centered on Inflammatory Bowel Disease (IBD) in both pediatric and adult populations, Barrett’s esophagus and progression to dysplasia, and Eosinophilic Esophagitis. He is also keenly involved in the application of Artificial Intelligence in IBD, particularly developing AI algorithms associated with IBD.

He has contributed to the field with his publication, "A Comparative Immunohistochemical Analysis of Small Round Cell Tumors of Childhood: Utility of Peripherin and Alpha-Internexin as Markers for Neuroblastomas," which showcases his dedication to advancing medical knowledge. Dr. Sonawala's commitment to pathology and his leadership in the GI and Liver Resource Committee underscore his role as a key expert in his field.

With a specialized focus on gastrointestinal (GI) pathology and breast pathology, Dr. Sreehari has extensive expertise in diagnosing cancers and inflammatory disorders of the GI tract, as well as cancers and benign breast diseases. Her dedication to histopathology is reflected in her meticulous approach to understanding and diagnosing complex conditions, contributing significantly to patient care.

Dr. Sreehari has several publications showcasing her research and findings. Outside of her professional life, Dr. Sreehari enjoys traveling and reading, which enrich her understanding of diverse cultures and perspectives. Her passion for her field, combined with her hobbies, makes her a well-rounded and dedicated pathologist committed to advancing medical science and improving patient outcomes.

After completing her medical degree, Dr. Stueck underwent Anatomical Pathology residency at Dalhousie University, becoming a fellow of the Royal College of Physicians and Surgeons of Canada, then subsequently a specialized Liver Pathology Fellowship at Icahn School of Medicine at Mount Sinai. Presently, she holds the position of Associate Professor at Dalhousie University and works as an Anatomical Pathologist specializing in Hepatobiliary and Gastrointestinal Pathology at Nova Scotia Health Authority.

Dr. Stueck is an active member of numerous professional associations and societies such as the International Liver Pathology Study Group (ELVES), Laennec Liver Pathology Society, Hans Popper Hepatopathology Society, and USCAP, among others. Her engagement in these organizations signifies her commitment to ongoing learning and collaboration.

Her research focus primarily lies in liver pathology, including regeneration, neoplasia, autoimmune disease, and hepatic graft-versus-host disease. Dr. Stueck has presented extensively at international, national, and regional conferences. She has authored various peer-reviewed publications, editorials, and reviews in prominent journals.

Outside her professional duties, Dr. Stueck actively engages in community service, including volunteer work, student mentorship, and organizing conferences. Her involvement reflects her dedication to both academic pursuits and community initiatives.

Dr. Ashley Stueck's commitment to liver pathology, her extensive contributions to research and academia, and her active involvement in professional associations underscore her impact and dedication in the field of Anatomical Pathology.

With a diverse educational background spanning multiple countries and prestigious institutions, Dr. Sur has consistently demonstrated a commitment to excellence in her academic and professional pursuits.

Dr. Monalisa Sur holds multiple fellowships and qualifications from renowned institutions, including the Royal College of Pathologists in the U.K., the Royal College of Physicians and Surgeons of Canada, and the Colleges of Medicine of South Africa, among others. Her specializations in anatomical pathology and clinical pathology have provided her with a comprehensive understanding of disease processes and diagnostic techniques.

Over the years, Dr. Sur has actively engaged in continuous professional development, staying at the forefront of advancements in the field. Her participation in numerous conferences, workshops, and specialized training programs across the world highlights her dedication to ongoing learning and innovation. Notably, she has attended conferences such as the United States and Canadian Academy of Pathology (USCAP) and participated in various leadership development programs.

Dr. Sur currently holds the position of Professor with Continuous Appointment Without Annual Review (CAWAR) at McMaster University, Hamilton, Ontario, Canada. She is a staff pathologist at Hamilton Health Sciences Corporation, serving at Juravinski Hospital and Cancer Center, Hamilton General Hospital, and St. Joseph’s Health Care. Her role extends to academic leadership in the Department of Pathology and Molecular Medicine, reflecting her commitment to education and research.

In addition to her professional roles, Dr. Sur maintains active medical licenses with the College of Physicians and Surgeons of Ontario, Health Professionals Council of South Africa, and the Punjab Medical Council, underscoring her commitment to medical practice and patient care.

Dr. Monalisa Sur's professional affiliations include membership in several esteemed organizations, such as the Canadian Association of Pathologists (CAP-ACP), United States-Canadian Academy of Pathology (USCAP), and the American Society of Clinical Pathology (ASCP). Her involvement in these organizations reflects her dedication to networking, knowledge sharing, and collaboration within the medical community.

Recognized for her outstanding contributions and expertise, Dr. Sur has received numerous awards and honors throughout her career. Notably, she was honored with the Distinguished Service Award from the Canadian Association of Pathologists (CAP-ACP) in 2022. Her recognition extends to teaching and research, as she received the Resident-Nominated Clinical Faculty Award for Excellence in Teaching in 2022.

Dr. Monalisa Sur's commitment to the medical field, her extensive qualifications, and her dedication to ongoing learning make her a respected and influential figure in the field of pathology. Her work serves as an inspiration to aspiring pathologists and underscores her significance in advancing healthcare and patient outcomes.